Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: A molecular target for Type 2 diabetes treatment

Current Diabetes Reviews

Volumn 9, Issue 3, 2013, Pages 228-236

  Pacheco, Paulo Anastácio Furtado ^a   Ferreira, Leonardo Gomes Braga ^a   Alves, Luiz Anastacio ^a   Faria, Robson Xavier ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antagonists; Diabetes; P2 receptors; Pancreatic B cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; PURINERGIC P2 RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DIABETIC DIET; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; WEIGHT REDUCTION;

ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; MICE; PHOSPHORYLATION; PURINERGIC P2 RECEPTOR AGONISTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RATS; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84878633000     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/1573399811309030004     Document Type: Article

References (77)

1. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci. 2006; 27(3): 166-76.
2. North RA. Molecular physiology of P2X receptors. Physiological reviews. 2002; 82(4): 1013-67.
3. Xu C, Xu W, Xu H, et al. Role of puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons. Brain Res Bull. 2012; 87(1): 37-43.
4. Chessell IP, Hatcher JP, Bountra C, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain. 2005; 114(3): 386-96.
5. Ji X, Naito Y, Hirokawa G, et al. P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension research: official journal of the Japanese Society of Hypertension. 2012; 35(2): 173-9.
6. Portales-Cervantes L, Nino-Moreno P, Salgado-Bustamante M, et al. The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis. Cellular immunology. 2012; 276(1-2): 168-75.
7. Di Virgilio F, Ferrari D, Adinolfi E. P2X(7): a growth-promoting receptor-implications for cancer. Purinergic signalling. 2009; 5(2): 251-6.
8. Sun SH. Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists. Molecular neurobiology. 2010; 41(2-3): 351-5.
9. Adinolfi E, Callegari MG, Cirillo M, et al. Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis. The Journal of biological chemistry. 2009; 284(15): 10120-8.
10. Burnstock G, Cocks T, Kasakov L, Wong HK. Direct evidence for ATP release from non-adrenergic, non-cholinergic (purinergic) nerves in the guinea-pig taenia coli and bladder. European journal of pharmacology. 1978; 49(2): 145-9.
11. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther. 1994; 64(3): 445-75.
12. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985; 16(5): 433-40.
13. Candela JL, Castrillon AM, Martin Hernandez D, Castilla Cortazar T. Effect of Glucose and Citrate on Insulin Secretion in Vitro by the Pancreas Pretreated with 2-Deoxyglucose. Medicina experimentalis International journal of experimental medicine. 1964; 11: 47-50.
14. Levine RA, Oyama S, Kagan A, Glick SM. Stimulation of insulin and growth hormone secretion by adenine nucleotides in primates. The Journal of laboratory and clinical medicine. 1970; 75(1): 30-6.
15. Novak I. Purinergic receptors in the endocrine and exocrine pancreas. Purinergic signalling. 2008; 4(3): 237-53.
16. Jacques-Silva MC, Correa-Medina M, Cabrera O, et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A. 2010; 107(14): 6465-70.
17. Gylfe E, Grapengiesser E, Dansk H, Hellman B. The neurotransmitter ATP triggers Ca2+ responses promoting coordination of pancreatic islet oscillations. Pancreas. 2012; 41(2): 258-63.
18. Petit P, Lajoix AD, Gross R. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences. 2009; 37(2): 67-75.
19. Fernandez-Alvarez J, Hillaire-Buys D, Loubatières-Mariani MM, Gomis R, Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas. 2001; 22(1): 69-71.
20. Burnstock G, Novak I. Purinergic signalling in the pancreas in health and disease. The Journal of endocrinology. 2012; 213(2): 123-41.
21. Richards-Williams C, Contreras JL, Berecek KH, Schwiebert EM. Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion. Purinergic signalling. 2008; 4(4): 393-405.
22. Coutinho-Silva R, Parsons M, Robson T, Burnstock G. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res. 2001; 306(3): 373-83.
23. Santini E, Cuccato S, Madec S, Chimenti D, Ferrannini E, Solini A. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype. Endocrinology. 2009; 150(6): 2596-602.
24. Ohtani M, Ohura K, Oka T. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells. Cell Physiol Biochem. 2011; 28(2): 355-66.
25. Wang CZ, Namba N, Gonoi T, Inagaki N, Seino S. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochemical and biophysical research communications. 1996; 220(1): 196-202.
26. Lee DH, Kim EG, Park KS, Jeong SW, Kong ID, Lee JW. Characteristics of P2X7-like receptor activated by adenosine triphosphate in HIT-T15 cells. Pancreas. 2007; 35(1): 53-62.
27. Ohtani M, Suzuki J, Jacobson KA, Oka T. Evidence for the possible involvement of the P2Y(6) receptor in Ca (2+) mobilization and insulin secretion in mouse pancreatic islets. Purinergic signalling. 2008; 4(4): 365-75.
28. Parandeh F, Abaraviciene SM, Amisten S, Erlinge D, Salehi A. Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors. Biochemical and biophysical research communications. 2008; 370(3): 499-503.
29. Amisten S, Meidute-Abaraviciene S, Tan C, et al. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia. 2010; 53(9): 1927-34.
30. Coutinho-Silva R, Parsons M, Robson T, Lincoln J, Burnstock G. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol. 2003; 204(1-2): 141-54.
31. Lugo-Garcia L, Filhol R, Lajoix AD, Gross R, Petit P, Vignon J. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization. European journal of pharmacology. 2007; 568(1-3): 54-60.
32. Lugo-Garcia L, Nadal B, Gomis R, Petit P, Gross R, Lajoix AD. Human pancreatic islets express the purinergic P2Y11 and P2Y12 receptors. Hormone and metabolic research = Hormon-und Stoffwechselforschung = Hormones et metabolisme. 2008; 40(11): 827-30.
33. Goodner CJ, Walike BC, Koerker DJ, et al. Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science. 1977; 195(4274): 177-9.
34. Salehi A, Qader SS, Grapengiesser E, Hellman B. Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon. Regul Pept. 2007; 144(1-3): 43-9.
35. Bertrand G, Chapal J, Loubatieres-Mariani MM. Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am J Physiol. 1986; 251(4 Pt 1): E416-21.
36. Léon C, Freund M, Latchoumanin O, et al. The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic signalling. 2005; 1(2): 145-51.
37. Hutton JC, Peshavaria M, Tooke NE. 5-Hydroxytryptamine transport in cells and secretory granules from a transplantable rat insulinoma. Biochem J. 1983; 210(3): 803-10.
38. Leitner JW, Sussman KE, Vatter AE, Schneider FH. Adenine nucleotides in the secretory granule fraction of rat islets. Endocrinology. 1975; 96(3): 662-77.
39. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X-and P2Yreceptor activating molecules. Mol Pharmacol. 2003; 64(4): 785-95.
40. Moreno-Navarrete JM, Fernandez-Real JM. Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis. Diabetes care. 2011; 34 Suppl 2: S335-41.
41. Yudkin JS, Yajnik CS, Mohamed-Ali V, Bulmer K. High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes care. 1999; 22(2): 363-4.
42. Fischer B, Chulkin A, Boyer JL, et al. 2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors. J Med Chem. 1999; 42(18): 3636-46.
43. Farret A, Filhol R, Linck N, et al. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues. Pharm Res. 2006; 23(11): 2665-71.
44. Eliahu S, Barr HM, Camden J, Weisman GA, Fischer B. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold. J Med Chem. 2010; 53(6): 2472-81.
45. Balasubramanian R, Ruiz de Azua I, Wess J, Jacobson KA. Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells. Biochemical pharmacology. 2010; 79(9): 1317-26.
46. Hourani SM. Purinoceptors and platelet aggregation. J Auton Pharmacol. 1996; 16(6): 349-52.
47. Jarvis GE, Humphries RG, Robertson MJ, Leff P. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol. 2000; 129(2): 275-82.
48. Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001; 409(6817): 202-7.
49. Angiolillo DJ, Bernardo E, Ramírez C, et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol. 2006; 48(2): 298-304.
50. Matsuno H, Tokuda H, Ishisaki A, Zhou Y, Kitajima Y, Kozawa O. P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes. J Clin Endocrinol Metab. 2005; 90(2): 920-7.
51. Ferreira IA, Mocking AI, Feijge MA, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2006; 26(2): 417-22.
52. Randriamboavonjy V, Fleming I. Platelet Function and Signaling in Diabetes Mellitus. Curr Vasc Pharmacol. 2012.
53. Randriamboavonjy V, Isaak J, Elgheznawy A, et al. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood. 2012; 120(2): 415-23.
54. Vazzana N, Ranalli P, Cuccurullo C, Davì G. Diabetes mellitus and thrombosis. Thromb Res. 2012; 129(3): 371-7.
55. Sarafoff N, Byrne RA, Sibbing D. Clinical use of clopidogrel. Curr Pharm Des. 2012.
56. Van der Meijden PE, Feijge MA, Giesen PL, Huijberts M, van Raak LP, Heemskerk JW. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost. 2005; 93(6): 1128-36.
57. Tan C, Salehi A, Svensson S, Olde B, Erlinge D. ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells. Cell Mol Life Sci. 2010; 67(3): 445-53.
58. Silva AM, Rodrigues RJ, Tomé AR, et al. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells. Pancreas. 2008; 36(3): 279-83.
59. Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol. 2003; 179(2): 188-99.
60. Migita K, Moriyama T, Koguchi M, et al. Modulation of P2X receptors in dorsal root ganglion neurons of streptozotocin-induced diabetic neuropathy. Neurosci Lett. 2009; 452(2): 200-3.
61. Petit P, Hillaire-Buys D, Manteghetti M, Debrus S, Chapal J, Loubatières-Mariani MM. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol. 1998; 125(6): 1368-74.
62. Poulsen CR, Bokvist K, Olsen HL, et al. Multiple sites of purinergic control of insulin secretion in mouse pancreatic betacells. Diabetes. 1999; 48(11): 2171-81.
63. Brissova M, Fowler MJ, Nicholson WE, et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005; 53(9): 1087-97.
64. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006; 103(7): 2334-9.
65. Xu GY, Li G, Liu N, Huang LY. Mechanisms underlying purinergic P2X3 receptor-mediated mechanical allodynia induced in diabetic rats. Mol Pain. 2011; 7: 60.
66. Coutinho-Silva R, Robson T, Beales PE, Burnstock G. Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes. Autoimmunity. 2007; 40(2): 108-16.
67. Glas R, Sauter NS, Schulthess FT, Shu L, Oberholzer J, Maedler K. Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival. Diabetologia. 2009; 52(8): 1579-88.
68. Lang PA, Merkler D, Funkner P, et al. Oxidized ATP inhibits Tcell-mediated autoimmunity. Eur J Immunol. 2010; 40(9): 2401-8.
69. Chen YG, Scheuplein F, Driver JP, et al. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice. J Immunol. 2011; 186(7): 4278-84.
70. García-Hernández MH, Portales-Cervantes L, Cortez-Espinosa N, et al. Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cellular immunology. 2011; 269(2): 135-43.
71. Bourzac JF, L'ériger K, Larrivée JF, et al. P2X7 receptor stimulation reduces glucose absorption by down-regulating glucose transporter 2 expression at the membrane of intestinal epithelial cells. J Cell Physiol. 2012.
72. Yelovitch S, Barr HM, Camden J, et al. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist. J Med Chem. 2012; 55(17): 7623-35.
73. Jacobson KA, Boeynaems JM. P2Y nucleotide receptors: promise of therapeutic applications. Drug discovery today. 2010; 15(13-14): 570-8. Epub 2010/07/03.
74. Bokvist K, Efanov A, Sandusky G, Sewing S, Treinies I, Gromada J. Bokvist K, Efanov A, Sandusky G, Sewing S, Treinies I, Gromada J. The P2Y4 pyrimidinergic receptor is important for nucleotide stimulation of insulin secretion in rat pancreatic beta-cells (Abstract). Diabetes Metab 29: 4S77-4S78, 2003.
75. Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP, Cloning and Chromosomal Localization of the Human P2Y1 Purinoceptor, Biochemical and Biophysical Research Communications, Volume 218, Issue 3, 26 January 1996, Pages 783-788, ISSN 0006-291X, 10.1006/bbrc.1996.0139.
76. Verspohl EJ, Johannwille B, Waheed A, Neye H, Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Can J Physiol Pharmacol, 2002; 80(6): p. 562-8.
77. Tan C, Ulrikke V, Siv S, David E, Björnet O, High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y13 receptor. Purinergic Signal, 2013; 9(1): p. 67-79.